anti-HER2-CAR-T
/ Shanghai First Song Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 06, 2024
A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors
(clinicaltrials.gov)
- P1 | N=9 | Recruiting | Sponsor: China Medical University, China | Not yet recruiting ➔ Recruiting
CAR T-Cell Therapy • Enrollment open • Metastases • Breast Cancer • Colorectal Cancer • Gastric Cancer • Gastrointestinal Cancer • HER2 Breast Cancer • Oncology • Solid Tumor • HER-2
October 25, 2023
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With HER2+ Locally Advanced and/ or Metastatic Solid Tumors
(clinicaltrials.gov)
- P1 | N=9 | Not yet recruiting | Sponsor: China Medical University, China
CAR T-Cell Therapy • Metastases • New P1 trial • Breast Cancer • Colorectal Cancer • Gastric Cancer • Gastrointestinal Cancer • HER2 Breast Cancer • Oncology • Solid Tumor • HER-2
1 to 2
Of
2
Go to page
1